Abstract:Light chain, or AL, amyloidosis is a pathological condition arising from systemic extracellular deposition of monoclonal immunoglobulin light chain variable domains in the form of insoluble amyloid fibrils, especially in the kidneys. Substantial evidence suggests that amyloid fibril formation from native proteins occurs via a conformational change leading to a partially folded intermediate conformation, whose subsequent association is a key step in fibrillation. In the present investigation, we have examined the properties of a recombinant amyloidogenic light chain variable domain, SMA, to determine whether partially folded intermediates can be detected and correlated with aggregation. The results from spectroscopic and hydrodynamic measurements, including far- and near-UV circular dichroism, FTIR, NMR, and intrinsic tryptophan fluorescence and small-angle X-ray scattering, reveal the build-up of two partially folded intermediate conformational states as the pH is decreased (low pH destabilized the protein and accelerated the kinetics of aggregation). A relatively nativelike intermediate, I(N), was observed between pH 4 and 6, with little loss of secondary structure, but with significant tertiary structure changes and enhanced ANS binding, indicating exposed hydrophobic surfaces. At pH below 3, we observed a relatively unfolded, but compact, intermediate, I(U), which was characterized by decreased tertiary and secondary structure. The I(U) intermediate readily forms amyloid fibrils, whereas I(N) preferentially leads to amorphous aggregates. Except at pH 2, where negligible amorphous aggregate is formed, the amorphous aggregates formed significantly more rapidly than the fibrils. This is the first indication that different partially folded intermediates may be responsible for different aggregation pathways (amorphous and fibrillar). The data support the hypothesis that amyloid fibril formation involves the ordered self-assembly of partially folded species that are critical soluble precursors of fibrils.

Why is Dimeric 3D Domain Swapping in Antibody Light Chains Missing from the Solution? Atomistic Insights Mechanisms

Structural and mutational analysis of a monomeric and dimeric form of a single domain antibody with implications for protein misfolding

Amyloid-like Fibrils from a Domain-swapping Protein Feature a Parallel, In-Register Conformation Without Native-like Interactions*

Theoretical Analysis of Structure of Antibody Light Chain Tetramer

Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta2-microglobulin variant

Intradomain Disulfide Bonds Impede Formation of the Alternatively Folded State of Antibody Chains

Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates

Three-dimensional domain swapping in the protein structure space.

Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements.

Structure and Energetic Basis of Overrepresented Λ Light Chain in Systemic Light Chain Amyloidosis Patients.

Conformational Differences in the Light Chain Constant Domain of Immunoglobulin G and Free Light Chain May Influence Proteolysis in AL Amyloidosis

Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain

Antibody Aggregation: Insights from Sequence and Structure

Effects of a reduced disulfide bond on aggregation properties of the human IgG1 CH3 domain

Delicate balance among thermal stability, binding affinity, and conformational space explored by single-domain VHH antibodies

Domain unfolding of monoclonal antibody fragments revealed by non-reducing SDS-PAGE

A conformational fingerprint for amyloidogenic light chains.

Appendant structure plays an important role in amyloidogenic cystatin dimerization prior to domain swapping.

Folding and oxidation of the antibody domain C(H)3

Molecular Recognition Between A-Specific Single-Domain Antibody And A Misfolded Aggregates

Binding symmetry and surface flexibility mediate antibody self-association